Akeso Completes HK$1.9 Billion Follow-On Public Offering
October 23, 2024
October 23, 2024
PALO ALTO, California, Oct. 23 -- Cooley, a law firm, issued the following news release:
Shanghai - October 21, 2024 - Cooley advised Akeso (Hong Kong Stock Exchange code: 9926.HK), a commercial-stage biopharmaceutical company committed to discovering, developing, manufacturing and commercializing innovative medicines that address global medical needs, on its HK$1.9 billion (approximately US$250 million) follow-on public offering. Akeso offered an aggregate of 31,700,000 shares, pri . . .
Shanghai - October 21, 2024 - Cooley advised Akeso (Hong Kong Stock Exchange code: 9926.HK), a commercial-stage biopharmaceutical company committed to discovering, developing, manufacturing and commercializing innovative medicines that address global medical needs, on its HK$1.9 billion (approximately US$250 million) follow-on public offering. Akeso offered an aggregate of 31,700,000 shares, pri . . .